Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
In vitro study of TLR4-NLRP3-inflammasome activation in innate immune response.
Methods Mol. Biol. 2700, 163-176 (2023)
Toll-like receptors (TLRs) are pivotal players in mediating immune responses. TLR4 is the main receptor for LPS, a strong activator of immune cells. LPS/TLR4-dependent pathway, by inducing NF-κB activation, is responsible for the release of several mediators, including IL-1β, one of the most powerful cytokines deeply involved in inflammatory and immune responses. The same pathway is also involved in NLRP3-inflammasome activation, essential for IL-1β maturation. NLRP3 is a major component of innate immune responses, being a crucial player of host immune defense against virus, bacterial, or fungal infections. NLRP3-inflammasome and IL-1β hyperactivation have been associated to the pathogenesis of a wide range of disorders and represent therapeutic targets for the development of new treatments of inflammasome-driven inflammatory and autoimmune diseases.Here, we describe an in vitro protocol to induce LPS/TLR4-dependent NLRP3-inflammasome/IL-1β activation in immune cells, in order to provide a useful assay to study the efficacy of different anti-inflammatory/immune-modulatory agents.
Impact Factor
Scopus SNIP
Altmetric
0.429
0.000
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Autoimmune Diseases ; Il-1β ; Inflammatory Diseases ; Lps ; Nf-κb ; Nlrp3-inflammasome ; Toll-like Receptor 4
Sprache
englisch
Veröffentlichungsjahr
2023
HGF-Berichtsjahr
2023
ISSN (print) / ISBN
1064-3745
e-ISSN
1940-6029
Zeitschrift
Methods in Molecular Biology
Quellenangaben
Band: 2700,
Seiten: 163-176
Verlag
Springer
Verlagsort
Berlin [u.a.]
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute for Allergy Research (IAF)
POF Topic(s)
30202 - Environmental Health
Forschungsfeld(er)
Allergy
PSP-Element(e)
G-505400-001
Scopus ID
85168428828
PubMed ID
37603180
Erfassungsdatum
2023-10-06